相似文献
1
Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line.
Genomic Med. 2008 Dec;2(3-4):113-25. doi: 10.1007/s11568-009-9080-y. Epub 2009 May 15.
2
Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
J Virol. 2018 Jul 17;92(15). doi: 10.1128/JVI.02202-17. Print 2018 Aug 1.
3
4
The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line.
Immunopharmacology. 1998 Jun;39(3):193-9. doi: 10.1016/s0162-3109(98)00017-4.
5
A Cross-Study Biomarker Signature of Human Bronchial Epithelial Cells Infected with Respiratory Syncytial Virus.
Adv Virol. 2016;2016:3605302. doi: 10.1155/2016/3605302. Epub 2016 May 4.
6
Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF.
Thorax. 2013 Jan;68(1):76-81. doi: 10.1136/thoraxjnl-2012-202288. Epub 2012 Sep 21.
7
Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages.
Am J Respir Cell Mol Biol. 1992 Apr;6(4):369-74. doi: 10.1165/ajrcmb/6.4.369.
8
Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
J Virol. 2015 Dec;89(24):12309-18. doi: 10.1128/JVI.02119-15. Epub 2015 Sep 30.
9
3-nitrotyrosine attenuates respiratory syncytial virus infection in human bronchial epithelial cell line.
Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L988-96. doi: 10.1152/ajplung.00378.2004. Epub 2005 Jan 14.
10
Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00113-20.
引用本文的文献
1
Nasopharyngeal and Peripheral Blood Type II Interferon Signature Evaluation in Infants during Respiratory Syncytial Virus Infection.
Medicina (Kaunas). 2024 Feb 2;60(2):259. doi: 10.3390/medicina60020259.
2
Malondialdehyde Acetaldehyde-Adduction Changes Surfactant Protein D Structure and Function.
Front Immunol. 2022 May 20;13:866795. doi: 10.3389/fimmu.2022.866795. eCollection 2022.
3
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.
Front Immunol. 2022 Apr 5;13:821730. doi: 10.3389/fimmu.2022.821730. eCollection 2022.
4
Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems.
IEEE Open J Eng Med Biol. 2020 Aug 6;1:220-227. doi: 10.1109/OJEMB.2020.3014798. eCollection 2020.
5
Deficiency in ST2 signaling ameliorates RSV-associated pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2021 Aug 1;321(2):H309-H317. doi: 10.1152/ajpheart.00018.2021. Epub 2021 Jun 25.
6
Identification of biological correlates associated with respiratory failure in COVID-19.
BMC Med Genomics. 2020 Dec 11;13(1):186. doi: 10.1186/s12920-020-00839-1.
7
The Importance of AGO 1 and 4 in Post-Transcriptional Gene Regulatory Function of tRF5-GluCTC, an Respiratory Syncytial Virus-Induced tRNA-Derived RNA Fragment.
Int J Mol Sci. 2020 Nov 20;21(22):8766. doi: 10.3390/ijms21228766.
8
Metabolic changes during respiratory syncytial virus infection of epithelial cells.
PLoS One. 2020 Mar 26;15(3):e0230844. doi: 10.1371/journal.pone.0230844. eCollection 2020.
9
Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection.
Viruses. 2019 Aug 11;11(8):739. doi: 10.3390/v11080739.
10
Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein.
mSphere. 2018 Nov 14;3(6):e00549-18. doi: 10.1128/mSphereDirect.00549-18.
本文引用的文献
1
Pulmonary peptidergic innervation remodeling and development of airway hyperresponsiveness induced by RSV persistent infection.
Peptides. 2008 Jan;29(1):47-56. doi: 10.1016/j.peptides.2007.10.020. Epub 2007 Nov 4.
2
Emerging role of dendritic cells in respiratory viral infection.
J Mol Med (Berl). 2007 Oct;85(10):1057-68. doi: 10.1007/s00109-007-0212-3. Epub 2007 May 22.
3
Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells.
J Immunol. 2007 Sep 1;179(5):2741-7. doi: 10.4049/jimmunol.179.5.2741.
4
Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells.
J Gen Virol. 2007 Feb;88(Pt 2):570-581. doi: 10.1099/vir.0.82187-0.
5
Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth.
J Virol. 2007 Feb;81(4):1786-95. doi: 10.1128/JVI.01420-06. Epub 2006 Dec 6.
6
Biological fate and clinical implications of arginine metabolism in tissue healing.
Wound Repair Regen. 2006 Jul-Aug;14(4):376-86. doi: 10.1111/j.1743-6109.2006.00151.x.
7
Arginine: beyond protein.
Am J Clin Nutr. 2006 Feb;83(2):508S-512S. doi: 10.1093/ajcn/83.2.508S.
8
The arginine-arginase balance in asthma and lung inflammation.
Eur J Pharmacol. 2006 Mar 8;533(1-3):253-62. doi: 10.1016/j.ejphar.2005.12.047. Epub 2006 Feb 3.
9
Arginine metabolism in vascular biology and disease.
Vasc Med. 2005 Jul;10 Suppl 1:S83-7. doi: 10.1177/1358836X0501000112.
10
Antiviral immune responses and lung inflammation after respiratory syncytial virus infection.
Proc Am Thorac Soc. 2005;2(2):121-5. doi: 10.1513/pats.200504-032AW.
Zotero 插件